Literature DB >> 9560156

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

T Kitada1, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu.   

Abstract

Parkinson's disease is a common neurodegenerative disease with complex clinical features. Autosomal recessive juvenile parkinsonism (AR-JP) maps to the long arm of chromosome 6 (6q25.2-q27) and is linked strongly to the markers D6S305 and D6S253; the former is deleted in one Japanese AR-JP patient. By positional cloning within this microdeletion, we have now isolated a complementary DNA done of 2,960 base pairs with a 1,395-base-pair open reading frame, encoding a protein of 465 amino acids with moderate similarity to ubiquitin at the amino terminus and a RING-finger motif at the carboxy terminus. The gene spans more than 500 kilobases and has 12 exons, five of which (exons 3-7) are deleted in the patient. Four other AR-JP patients from three unrelated families have a deletion affecting exon 4 alone. A 4.5-kilobase transcript that is expressed in many human tissues but is abundant in the brain, including the substantia nigra, is shorter in brain tissue from one of the groups of exon-4-deleted patients. Mutations in the newly identified gene appear to be responsible for the pathogenesis of AR-JP, and we have therefore named the protein product 'Parkin'.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560156     DOI: 10.1038/33416

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1596 in total

1.  Keio Mutation Database (KMDB) for human disease gene mutations.

Authors:  S Minoshima; S Mitsuyama; S Ohno; T Kawamura; N Shimizu
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The KMDB/MutationView: a mutation database for human disease genes.

Authors:  S Minoshima; S Mitsuyama; M Ohtsubo; T Kawamura; S Ito; S Shibamoto; F Ito; N Shimizu
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

3.  Parkinson's disease genetics comes of age.

Authors:  P Jarman; N Wood
Journal:  BMJ       Date:  1999-06-19

4.  TRIADs: a new class of proteins with a novel cysteine-rich signature.

Authors:  B A van der Reijden; C A Erpelinck-Verschueren; B Löwenberg; J H Jansen
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

5.  Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.

Authors:  M Periquet; C Lücking; J Vaughan; V Bonifati; A Dürr; G De Michele; M Horstink; M Farrer; S N Illarioshkin; P Pollak; M Borg; C Brefel-Courbon; P Denefle; G Meco; T Gasser; M M Breteler; N Wood; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  2001-02-14       Impact factor: 11.025

6.  Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

Authors:  L Stefanis; K E Larsen; H J Rideout; D Sulzer; L A Greene
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 7.  Ischemic injury and faulty gene transcripts in the brain.

Authors:  P K Liu; R G Grossman; C Y Hsu; C S Robertson
Journal:  Trends Neurosci       Date:  2001-10       Impact factor: 13.837

8.  Exclusion of the Nurr1 gene in autosomal recessive Parkinson's disease.

Authors:  Nina Rawal; Magali Periquet; Alexandra Dürr; Giuseppe de Michele; Vincenzo Bonifati; Helio A Teive; Salmo Raskin; Joao Guimaraes; Yves Agid; Alexis Brice
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

9.  Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray.

Authors:  Silvia Mandel; Edna Grünblatt; Gila Maor; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 10.  Orchestrating the unfolded protein response in health and disease.

Authors:  Randal J Kaufman
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.